Kotak Mutual Fund decreased its stake in Acutaas Chemicals from 3.95% to 3.53%, selling 3,45,594 shares for ₹120.8 Cr at ₹3495.20 apiece.
A research and development-driven manufacturer of specialty chemicals, Acutaas Chemical produces Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients for new chemical entities and innovative drug formulations. The company also supplies materials for agrochemicals and fine chemicals, serving global pharmaceutical and chemical industries. Its distinctive strength lies in vertically integrated manufacturing capabilities and specialized compound development through rigorous in-house research and technical expertise.
Wholly owned subsidiary of Kotak Mahindra Bank, one of India's leading private banks. Manages over Rs 4.5 lakh crore in AUM. MD Nilesh Shah is a fixture in Indian financial media and one of the most quoted fund managers in the country. Known for disciplined quality growth positioning and clear communication of investment rationale to investors.